Cancer
NICE recommends Celgene’s Revlimid combo for follicular lymphoma
February 27, 2020Sales and Marketing Cancer, Celgene, NICE, Revlimid, follicular lymphoma, pharma
NICE has chosen to recommend Celgene’s Revlimid (lenalidomide) for use on the NHS, it has emerged, alongside Genentech’s Rituxan (rituximab), …
New Keytruda dosing schedule rejected in six cancers by the FDA
February 20, 2020Sales and Marketing Cancer, FDA, MSD, keytruda, pharma
MSD’s blockbuster immunotherapy Keytruda has been stopped in its tracks by the FDA after the US regulator rejected its application …
Bristol-Myers Squibb demonstrates potential for long-term survival in kidney cancer patients treated with Opdivo plus Yervoy
February 20, 2020Business Services Cancer, Cancers, Yervoy, opdivo, renacl cell carcinoma, renal cancer
Bristol-Myers Squibb has announced updated results from trialing Opdivo (nivolumab) plus Yervoy (ipilimumab) versus sunitinib in patients with previously untreated …
GlaxoSmithKline acquires two solid tumor cell therapies from Immatics for $50 million
February 20, 2020Business Services Cancer, cancer cells, celluar immunotherapies, immunotherapies
GlaxoSmithKline has struck a deal to access two Immatics T-cell receptor (TCR) therapeutics. The deal sees GSK pay $50 million …
Women who take statins could be less likely to develop ovarian cancer, study finds
February 19, 2020Research and Development, Sales and Marketing Cancer, Cancer Research UK, cholesterol, ovarian cancer, statins
A study by Cancer Research UK has found that women who take statins, drugs that lower cholesterol, are less likely …
Eisai releases new Phase 2 data for levatinib+everolimus combo in advanced kidney cancer
February 17, 2020Research and Development, Sales and Marketing Cancer, Eisai, Kidney cancer, Lenvima, pharma, renal cell carcinoma
New Phase 2 data has been revealed for Eisai’s Lenvima (levatinib), delivered alongside Novartis’ everolimus, for the treatment of unresectable …
NICE does not recommend cancer drug combination to the NHS
February 13, 2020Business Services Cancer, Kidney cancer, NHS, NICE, keytruda, kidney disease
NICE has published draft guidance that does not recommend a new drug combination to combat untreated advanced renal cell carcinoma …
ICR identifies key “microRNA” gene driving chemotherapy resistance in cancer
February 12, 2020Research and Development Cancer, ICR, pharma
Researchers at the Institute of Cancer Research have discovered that a small RNA molecule known as microRNA gene MIR1249 contributes …
Seattle Genetics and Astellas unveil positive results for Padcev-Keytruda treatment for bladder cancer
February 12, 2020Research and Development Astellas, Cancer, Seattle Genentics, bladder, bladder cancer, keytruda, monotherapy
Seattle Genetics and Astellas reported positive results from their trials of Padcev plus Keytruda in treating bladder cancer. The data …
Virus DNA found in cancer cells
February 6, 2020Business Services Cancer, Cancer Virus, HPV, cancer research
The first comprehensive survey of viruses found with different types of cancer has been conducted by researchers. Researchers from the …
Landmark study set to transform cancer treatment
February 6, 2020Business Services Cancer, cancer breast, cancer mutations, cancer research, cancer treatment
Over a thousand scientists have built the most detailed picture of cancer ever in a landmark study. Their research was …
BMS pulls Opdivo+Yervoy combo in EU for advanced non-small cell lung cancer
February 3, 2020Sales and Marketing BMS, Cancer, Europe, Yervoy, lung cancer, opdivo
Bristol-Myers Squibb has confirmed it has withdrawn its application with the European Commission for its combination of Opdivo (nivolumab) and …
Prostate Cancer becomes most commonly diagnosed cancer in England
January 28, 2020Manufacturing and Production Cancer, Cancer diagnoses, NHS England, breast cancer, prostate cancer
Prostate cancer has overtaken breast cancer to be the most commonly diagnosed cancer for the first time in England, latest …
Realising the potential of greater collaboration for women living with cancer
January 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Merck KGaA, feature, pharma, women
Following the launch of a new global report, ‘Supporting women with cancer’, Lynn Talyroe, Senior Vice President, Head of Healthcare …
FDA greenlights its first therapy for advanced epithelioid sarcoma population
January 27, 2020Sales and Marketing Cancer, Epizyme, FDA, Tazverik, pharma
The FDA has revealed the approval of its first therapy for the treatment of metastatic or locally advanced epithelioid sarcoma, …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
